Lentiviral Expression Systems Market

Lentiviral are vectors that are derived from the virus known as human immunodeficiency virus and is used to transfer gene in the cells, such as mammalian cell and Others. Lentiviruses are used for transfection in non-dividing and actively dividing cell. This acts as an advantage to anOthers type of retrovirus. The lentiviruses fall in the category of a retrovirus. The lentiviral expression system is developed, which can influence the gene of interest. The commercially available lentiviral expression systems are available in combination with tag sequence, reporter gene, promoters and multicistronic vectors are also available for desired protein expression. These vectors are used for research and development purpose recombinant protein expression, protein characterization, in-vitro transcription, and Others functional arrays.
Lentiviral Expression Systems Market contains market size and forecasts of Lentiviral Expression Systems in Global, including the following market information:
Global Lentiviral Expression Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Lentiviral Expression Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lentiviral Promoter Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lentiviral Expression Systems include Dharmacon, Thermo Fisher Scientific, Merck KGaA, Takara Bio, ABM Industries, Cell Biolabs, GeneCopoeia, System Biosciences and Fujifilm Diosynth Biotechnologies and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lentiviral Expression Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lentiviral Expression Systems Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lentiviral Expression Systems Market Segment Percentages, by Type, 2021 (%)
Lentiviral Promoter
Lentiviral Fusion Tags
Lentivirus Packaging Systems
Others
Global Lentiviral Expression Systems Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lentiviral Expression Systems Market Segment Percentages, by Application, 2021 (%)
Biotechnology Companies
Pharmaceutical Companies
Contract Research Organizations
Academic/Research Institutes
Others
Global Lentiviral Expression Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lentiviral Expression Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lentiviral Expression Systems revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Lentiviral Expression Systems revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dharmacon
Thermo Fisher Scientific
Merck KGaA
Takara Bio
ABM Industries
Cell Biolabs
GeneCopoeia
System Biosciences
Fujifilm Diosynth Biotechnologies
ATUM